Sable Bio is a biotechnology company focused on advancing gene therapies through its proprietary platform that leverages synthetic biology and gene editing technologies. The company aims to address various genetic disorders by developing innovative treatments that enhance the precision and efficacy of gene delivery. Sable Bio's approach emphasizes the use of engineered biological systems to improve therapeutic outcomes and minimize side effects, positioning it as a key player in the evolving landscape of genetic medicine.